- Efficacy and safety of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma as first-line therapy
-
Oh MJ, Lee HJ, Lee SH
- KMID: 1705207
- Clin Mol Hepatol.
- 2013 Sep;19(3):288-299.
- doi: 10.3350/cmh.2013.19.3.288
BACKGROUND/AIMS: Hepatic arterial infusion chemotherapy (HAIC) with 5-fluorouracil and cisplatin for intractable advanced hepatocellular carcinoma (HCC) may have survival benefits. We aimed to determine the efficacy and safety of HAIC... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Therapy-related Acute Myeloid Leukemia associated with inv(16)
-
Lee SY, Kim M, Lim J, Kim Y, Han K, Kim SY, Kim HJ, Park IY
- KMID: 1121654
- Korean J Lab Med.
- 2007 Feb;27(1):19-21.
- doi: 10.3343/kjlm.2007.27.1.19
The inv(16)(p13q22) is found in de novo AML and is closely associated with the FAB subtype M4eo. The inv(16) is rarely reported in therapy-related AML (t-AML) patients. Herein, we report... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients
-
Mabuchi S, Isohashi F, Okazawa M, Kitada F, Maruoka S, Ogawa K, Kimura T
- KMID: 2413856
- J Gynecol Oncol.
- 2017 Jan;28(1):e15.
- doi: 10.3802/jgo.2017.28.e15
OBJECTIVE: To evaluate the efficacy and toxicity of paclitaxel plus carboplatin (TC)-based concurrent chemoradiotherapy (CCRT) followed by consolidation chemotherapy in the International Federation of Gynecology and Obstetrics (FIGO) stage IIIB/IVA... -
- CITED
-
- Close
- SHARE
-
- Close
- A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
-
Yang H, Woo HY, Lee SK, Han JW, Jang B, Nam HC, Lee HL, Lee SW, Song DS, Song MJ, Oh JS, Chun HJ, Jang JW, Lozada A, Bae SH, Choi JY, Yoon SK
- KMID: 2413116
- Clin Mol Hepatol.
- 2017 Jun;23(2):128-137.
- doi: 10.3350/cmh.2016.0071
BACKGROUND/AIMS: Metronomic chemotherapy (MET) is frequently administered in comparatively low doses as a continuous chemotherapeutic agent. The aim of this study was to evaluate the feasibility and overall survival (OS)... -
- CITED
-
- Close
- SHARE
-
- Close
